ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 127 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,810,483 | +95.2% | 130,538 | +171.7% | 0.00% | – |
| Q4 2023 | $1,439,999 | +96.9% | 48,048 | +34.6% | 0.00% | – |
| Q3 2023 | $731,391 | -73.1% | 35,695 | -73.9% | 0.00% | -100.0% |
| Q2 2023 | $2,719,031 | +546.5% | 136,841 | +457.4% | 0.00% | – |
| Q1 2023 | $420,576 | +30.6% | 24,552 | +49.2% | 0.00% | – |
| Q4 2022 | $321,985 | +77.9% | 16,453 | +45.0% | 0.00% | – |
| Q3 2022 | $181,000 | +1.1% | 11,346 | -12.7% | 0.00% | – |
| Q2 2022 | $179,000 | -25.1% | 12,996 | +19.0% | 0.00% | – |
| Q4 2021 | $239,000 | -78.5% | 10,925 | -70.6% | 0.00% | – |
| Q3 2021 | $1,111,000 | -42.0% | 37,165 | -14.1% | 0.00% | -100.0% |
| Q2 2021 | $1,917,000 | +61.1% | 43,288 | +61.4% | 0.00% | – |
| Q1 2021 | $1,190,000 | -36.1% | 26,817 | -21.0% | 0.00% | -100.0% |
| Q4 2020 | $1,861,000 | +309.9% | 33,935 | +70.9% | 0.00% | – |
| Q3 2020 | $454,000 | – | 19,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |